OVERLAND PARK, KS - December 12 2022 – Dr. Vince Clinical Research (DVCR) announced the addition of highly experienced investigator George J. Atiee, M.D. to the medical team at its world-class clinical pharmacology unit. Dr. Atiee has been practicing medicine with a...
News
Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial
OVERLAND PARK, Kan. - November 8, 2022 – Dr. Vince Clinical Research (DVCR), a world-class early phase contract research organization (CRO) specializing in the conduct of Phase I clinical trials, today announced that it has administered the first dose in Ensysce...
Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD
Study Conducted by Dr. Vince Clinical Research KANSAS CITY, Kan. - November 01 2022 - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline...
Dr. Vince Clinical Research Opens Industry-Leading Clinical Pharmacology Unit
OVERLAND PARK, Kan.- September 20 2022 -Dr. Vince Clinical Research (DVCR), today announced the launch of its new, world-class clinical pharmacology unit and headquarters in Overland Park, Kansas. The custom-built, green-inspired research complex was intentionally...
WCG IRB Expands Phase I Review Services, Partners with Dr. Vince Clinical Research
PRINCETON, N.J. & OVERLAND PARK, Kan.- September 13 2022 - ,the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the expansion of its Phase I review services, providing purpose-built...
Dr. Vince Clinical Research Hires Two Industry Veterans, Bringing Over 50 Years’ Combined Research Experience
OVERLAND PARK, Kan - July 26, 2022 – Dr. Vince Clinical Research (DVCR), a world-class contract research organization (CRO) specializing in early phase clinical trials, today announced the addition of two key leadership roles to its Phase I research team. Michelle...
Dr. Vince Clinical Research Announces Addition of Principal Investigator Steven Hull, M.D.
OVERLAND PARK, KS - December 7 2021 – Dr. Vince Clinical Research (DVCR) added depth to its medical team with the addition of industry veteran Steven Hull, M.D., FCCP, FAASM, as a Principal Investigator for the new clinical research organization. Dr. Hull joins DVCR...
Industry Veteran Launches New CRO, Dr. Vince Clinical Research, and Begins Headquarters Construction
OVERLAND PARK, KS. - October 26 2021 – Dr. Brad Vince announced he has founded a new clinical research organization and is building a cutting-edge headquarters and research complex in Kansas City. The organization, Dr. Vince Clinical Research, P.A., will formally...